0001140361-23-050839.txt : 20231101 0001140361-23-050839.hdr.sgml : 20231101 20231101161520 ACCESSION NUMBER: 0001140361-23-050839 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20231030 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231101 DATE AS OF CHANGE: 20231101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nuwellis, Inc. CENTRAL INDEX KEY: 0001506492 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 680533453 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35312 FILM NUMBER: 231368452 BUSINESS ADDRESS: STREET 1: 12988 VALLEY VIEW ROAD CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 BUSINESS PHONE: 952-345-4200 MAIL ADDRESS: STREET 1: 12988 VALLEY VIEW ROAD CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 FORMER COMPANY: FORMER CONFORMED NAME: CHF Solutions, Inc. DATE OF NAME CHANGE: 20170523 FORMER COMPANY: FORMER CONFORMED NAME: Sunshine Heart, Inc. DATE OF NAME CHANGE: 20101124 8-K 1 ef20013762_8k.htm 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 30, 2023

Nuwellis, Inc.
(Exact Name of Registrant as Specified in its Charter)

Delaware
001-35312
No. 68-0533453
(State or Other Jurisdiction of Incorporation or Organization)
(Commission File Number)
(I.R.S. Employer Identification No.)

12988 Valley View Road, Eden Prairie, MN 55344
(Address of Principal Executive Offices) (Zip Code)

(952) 345-4200
(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, par value $0.0001 per share
NUWE
Nasdaq Capital Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
Appointment of Archelle Georgiou (Feldshon), M.D.

On October 30, 2023, the Board of Directors (the “Board”) of Nuwellis, Inc., a Delaware corporation (the “Company”) approved, effective as of November 1, 2023, the appointment of Archelle Georgiou (Feldshon), M.D. to its Board. Dr. Georgiou has been designated as a Class II director, whose term will expire at the Company’s annual meeting of stockholders in 2024.  The appointment of Dr. Georgiou was recommended to the Board by its Nominating and Corporate Governance Committee. The Board has determined that Dr. Georgiou satisfies all of the independence criteria set forth in the Nasdaq rules, and is therefore “independent” for purposes of serving on the Board. Dr. Georgiou is also expected to serve as the Chair of the Nominating and Corporate Governance Committee and as a member of the Compensation Committee.

Dr. Georgiou is President of Georgiou Consulting, LLC. Since January 2008, Georgiou Consulting, LLC has offered strategic advisory services to companies committed to consumer-centered healthcare. Dr. Georgiou has held executive leadership positions in managed care, investment banking, and medical device companies. She has served as Chief Medical Officer and senior executive at UnitedHealth Group from March 1995 to December 2007. She's served as Chief Medical Officer and Chief Health Officer at Starkey Hearing Technologies from January 2020 to December 2022, Chairman of the Board of Directors at Children’s Hospital and Clinics of Minnesota since February 2022 and Executive in Residence at the University of Minnesota’s Carlson School of Management since July 2014. From May 2016 through May 2019, she was a Director for Tivity Health, Inc. and served on the governance and compensation committees. She has additional previous experience serving on public as well as non-profit boards. Dr. Georgiou is a published author and has over 16 years of experience as an on-air TV medical correspondent where she simplifies complex healthcare information for viewers. Dr. Georgiou received her M.D. degree from the Johns Hopkins School of Medicine and was board-certified in Internal Medicine.

There are no arrangements or understandings between Dr. Georgiou and any other persons pursuant to which she was appointed as a director of the Company. There are no family relationships between Dr. Georgiou and any director, executive officer, or any person nominated or chosen by the Company to become a director or executive officer.

In accordance with the Company’s Non-Employee Director Compensation Policy (the “Policy”), Dr. Georgiou is entitled to receive a $45,000 annual retainer for service as a Board member. Dr. Georgiou will also be entitled to receive an additional $5,000 for her role as a member of the Compensation Committee and $10,000 for her role as Chair of the Nominating and Corporate Governance Committee, annually.

Appointment of David McDonald

On October 30, 2023, the Board of the Company also approved, effective as of November 1, 2023, the appointment of David McDonald to its Board. Mr. McDonald has been designated as a Class I director, whose term will expire at the Company’s annual meeting of stockholders in 2026.  The appointment of Mr. McDonald was recommended to the Board by its Nominating and Corporate Governance Committee. The Board has determined that Mr. McDonald satisfies all of the independence criteria set forth in the Nasdaq rules, and is therefore “independent” for purposes of serving on the Board. Mr. McDonald is also expected to serve as a member of the Audit Committee and as a member of the Nominating and Corporate Governance Committee of the Board. The Board has determined that Mr. McDonald qualifies as a “financial expert” pursuant to the Securities and Exchange Commission rules in connection with his appointment to the Audit Committee.

Mr. McDonald serves as head of Life Science Investment Banking at Lake Street Capital Markets (“Lake Street”), raising almost $6 billion in financing for clients since joining the firm in January 2015. Immediately prior to joining Lake Street, Mr. McDonald worked in the oncology industry serving as a Senior Financial and Business Development Executive for SillaJen Biotherapeutics from June 2013 to December 2015, Delcath Systems from September 2009 to May 2013 and AngioDynamics from July 2008 to September 2009. In addition, Mr. McDonald has over 35 years of capital markets experience, serving the needs of emerging growth companies as a healthcare investment banker, equity research analyst, and investor with RBC Capital Markets from May 2000 to June 2005, Investment Advisors, Inc. from September 1994 to February 2000, Wessels, Arnold & Henderson (since acquired by RBC) from January 1989 to September 1994, American Express from June 1986 to December 1989 and Adams, Harkness & Hill (since acquired by Canaccord Genuity) from September 1982 to May 1986.  Mr. McDonald received his BA in Economics from St. Olaf College.


There are no arrangements or understandings between Mr. McDonald and any other persons pursuant to which he was appointed as a director of the Company. There are no family relationships between Mr. McDonald and any director, executive officer, or any person nominated or chosen by the Company to become a director or executive officer.

In accordance with the Company’s Policy, Mr. McDonald is entitled to receive a $45,000 annual retainer for service as a Board member. Mr. McDonald will also be entitled to receive an additional $7,500 for his role as a member of the Audit Committee and $5,000 for his role as a member of the Nominating and Corporate Governance Committee, annually.

The Company expects to enter into the Company’s standard form of indemnity agreement with both Mr. McDonald and Dr. Georgiou. The indemnity agreement provides, among other things, that the Company will indemnify each director for certain expenses which he or she may be required to pay in connection with certain claims to which he or she may be made a party by reason of his or her position as a director of the Company, and otherwise to the fullest extent permitted under Delaware law and the Company’s Third Amended and Restated Bylaws. The form of indemnity agreement was filed as Exhibit 10.1 on the Company’s Form 10 filed on September 30, 2011, and is incorporated herein by reference.

A copy of the Company’s press release dated November 1, 2023 announcing the appointments of Mr. McDonald and Dr. Georgiou to the Board is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Resignation of Jon Salveson

On October 31, 2023, Mr. Jon Salveson provided notice of his resignation from the Board of the Company, and from his role as member of the Compensation Committee, effective immediately. Mr. Salveson’s resignation was not the result of any disagreement with the Company regarding the Company’s operations, policies or practices.

Item 9.01
Financial Statements and Exhibits.

(d) Exhibits

Number
 
Description
 
Press Release dated November 1, 2023.
104
 
Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 1, 2023
NUWELLIS, INC.
   
 
By:
/s/ Nestor Jaramillo, Jr
 
 
Name:
Nestor Jaramillo, Jr.
 
 
Title:
President and Chief Executive Officer
 



EX-99.1 2 ef20013762_ex99-1.htm EXHIBIT 99.1
Exhibit 99.1


Nuwellis Announces Board of Directors Transition

Nuwellis Announces Appointment of Dr. Archelle Georgiou, MD and Dave McDonald to its Board of Directors

MINNEAPOLIS, November 1, 2023 (GLOBE NEWSWIRE) – Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the appointment of Dave McDonald and Archelle Georgiou, MD, to its board of directors, effective November 1, 2023.

“With decades of experience and leadership in their respective fields, we welcome Dave and Archelle to our board. Dave’s significant experience in finance and strategy will provide key insights to our board as we advance our growth and expansion initiatives.  In turn, our board will benefit from perspectives gained from Archelle’s healthcare policy, clinical, and patient education experience in bringing medical decisions closer to patients and caregivers. We look forward to our collaboration with Dave and Archelle as we continue to drive market penetration of our Aquadex® ultrafiltration therapy for patients with fluid overload unresponsive to current standard of care,” said Mr. Jaramillo, President and CEO of Nuwellis.

Mr. McDonald serves as Head of Life Science Investment Banking at Lake Street Capital Markets, raising $6 billion in financing for clients since joining the firm. His extensive industry and Capital Markets experience provide a unique perspective to Lake Street clients. Immediately prior to joining Lake Street, Mr. McDonald spent seven years in the oncology industry, serving as a Senior Financial and Business Development Executive for SillaJen Biotherapeutics, Delcath Systems, and AngioDynamics. In addition, he has more than 35 years of Capital Markets experience serving the needs of emerging growth companies as a Healthcare Investment Banker, Equity Research Analyst, and Investor with RBC Capital Markets, Craig-Hallum, Canaccord Genuity, and American Express. Mr. McDonald received his BA in Economics from St. Olaf College.

Dr. Georgiou is a physician with over 16 years of experience in leadership positions in managed care, investment banking, and medical device companies, including serving as Chief Medical Officer and Senior Executive at UnitedHealth Group, and currently serves as the Chair of the Board of Directors at Children’s Hospital and Clinics of Minnesota and Executive in Residence at the University of Minnesota's Carlson School of Management. In addition to her business leadership experience, Dr. Georgiou has produced and aired more than 2,000 news segments that simplify complex healthcare information for viewers. As a nationally recognized consumer advocate, Dr. Georgiou is passionate about helping people make data-driven decisions. Dr. Georgiou has been featured on CNN and Good Morning America, and has shared her thought leadership at events hosted by the World Bank, Mayo Clinic, Gallup, and AARP. Dr. Georgiou holds a degree from the Johns Hopkins School of Medicine and was board-certified in Internal Medicine.


In addition, Nuwellis announced that Jon Salveson is stepping down from the Board after 10 years of outstanding service. “During Jon’s tenure Nuwellis has benefitted consistently from his judgment, counsel, and market insights. We thank Jon for his service and recognize the numerous demands on his time that make his continued Board service challenging,” said Mr. Jaramillo. “I’m grateful for all the advice he provided during his time on the Board.”

About Nuwellis

Nuwellis, Inc. (Nasdaq: NUWE) is a medical technology company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. The company is focused on commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, Minnesota with a wholly owned subsidiary in Ireland. For more information visit www.nuwellis.com or visit us on LinkedIn or Twitter.

About the Aquadex SmartFlow® System

The Aquadex SmartFlow system delivers clinically proven therapy using a simple, flexible, and smart method of removing excess fluid from patients suffering from hypervolemia (fluid overload). The Aquadex SmartFlow system is indicated for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kg or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered by a health care provider, within an outpatient or inpatient clinical setting, under physician prescription, both having received training in extracorporeal therapies.

CONTACTS

INVESTORS:
Vivian Cervantes
Gilmartin Group
ir@nuwellis.com

 

EX-101.SCH 3 nuwe-20231030.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 nuwe-20231030_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 5 nuwe-20231030_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 image00001.jpg begin 644 image00001.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document and Entity Information
Oct. 30, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 30, 2023
Entity File Number 001-35312
Entity Registrant Name Nuwellis, Inc.
Entity Central Index Key 0001506492
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 68-0533453
Entity Address, Address Line One 12988 Valley View Road
Entity Address, City or Town Eden Prairie
Entity Address, State or Province MN
Entity Address, Postal Zip Code 55344
City Area Code 952
Local Phone Number 345-4200
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol NUWE
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
XML 8 ef20013762_8k_htm.xml IDEA: XBRL DOCUMENT 0001506492 2023-10-30 2023-10-30 false 0001506492 NASDAQ 8-K 2023-10-30 Nuwellis, Inc. DE 001-35312 68-0533453 12988 Valley View Road Eden Prairie MN 55344 952 345-4200 Common Stock, par value $0.0001 per share NUWE false false false false false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 M " #I@6%799!YDAD! #/ P $P @ &K$@ 6T-O;G1E C;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" #U$P ! end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 22 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://sunshineheart.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports ef20013762_8k.htm nuwe-20231030.xsd nuwe-20231030_lab.xml nuwe-20231030_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ef20013762_8k.htm": { "nsprefix": "nuwe", "nsuri": "http://sunshineheart.com/20231030", "dts": { "inline": { "local": [ "ef20013762_8k.htm" ] }, "schema": { "local": [ "nuwe-20231030.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "labelLink": { "local": [ "nuwe-20231030_lab.xml" ] }, "presentationLink": { "local": [ "nuwe-20231030_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 29, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://sunshineheart.com/role/DocumentAndEntityInformation", "longName": "000100 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c20231030to20231030", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20013762_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231030to20231030", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20013762_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://sunshineheart.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 16 0001140361-23-050839-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-23-050839-xbrl.zip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

/\82+_,/VA_\!4$L! A0# M% @ Z8%A5V8BQ9UJ&@ ,I8 !$ ( ! &5F,C P M,3,W-C)?.&LN:'1M4$L! A0#% @ Z8%A5\\V3>*["P HB4 !4 M ( !F1H &5F,C P,3,W-C)?97@Y.2TQ+FAT;5!+ 0(4 Q0 ( M .F!85<@T 6#1P, $@/ 1 " 83&UL4$L%!@ % 4 1P$ ,$X $! end